A Phase I and Pilot Study of the Effect of rhIL-7-hyFc (NT-I7) on CD4 Counts in Patients with High Grade Gliomas and Severe Treatment-Related CD4 Lymphopenia after Concurrent Radiation and Temozolomide

Grant

Date/time Interval

  • May 1, 2018 - April 30, 2021
  • Total Award Amount

  • 6000.00
  • Direct Costs

  • 4040.00
  • Sponsor Award Id

  • ABTC 1403
  • Contributor

  • Hassan Fathallah-Shaykh M.D., Ph.D.   Investigator  
  • Louis Nabors M.D.   Principal Investigator  
  • Mina Lobbous   Investigator  
  • Xiaosi Han   Investigator